4893 items matching your search terms.

Is timing important in systematic reviews of interventions for breast cancer?

Mieog, S Ghersi, D

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: Economic analysis of a randomised trial in 20 536 individuals

Mihaylova, B. Briggs, A. Armitage, J. Parish, S. Gray, A. Collins, R. Collins, R. Meade, T. Sleight, P. Armitage, J. Parish, S. Peto, R. Youngman, L. Buxton, M. De Bono, D. George, C. Fuller, J. Keech, A. Mansfield, A. Pentecost, B. Simpson, D. Warlow, C. McNamara, J. O'Toole, L. Doll, R. Wilhelmsen, L. Fox, K. M. Hill, C. Sandercock, P.
LANCET, 2005     DOI:10.1016/S0140-6736(05)63014-0

Recruitment and retention of research subjects

Mister, R Delahunty, N Grosbard, A

Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial

Nestel, PJ; Baghurst, K; Colquhoun, DM; Simes, RJ; Mehalski, K; White, HD; Tonkin, AM; Kirby, A; Pollicino, C; for the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Investigators,

Tissue inhibitor of metalloproteinase (TIMP-1) is a predictor of recurrent cardiovascular events in the LIPID Study

Nestel, PJ; Blankenberg, S; Simes, RJ; Kirby, A; Tonkin, A

Tissue inhibitor of metalloproteinase (TIMP-1) is a strong predictor of recurrent cardiovascular events in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study. The LIPID study investigators

Nestel, PJ; Blankenberg, S; Simes, RJ; Kirby, A; Tonkin, A

Feasibility and risks of pre-operative chemotherapy with FOLFOX 4 and surgery for resectable colorectal cancer liver metastases. Interim results of the EORTC Intergroup randomized phase III study 40983

Nordlinger, B Sorbye, H Debois, M Praet, M Glimelius, B Poston, GJ Schlag, PM Walpole, ET Bechstein, W Gruenberger, T

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review

Nowak, AK Stockler, MR Chow, PK Findlay, M

A simple prognostic score for the re-infarction risk following fibrinolytic therapy for myocardial infarction: data from HERO-2

O'Connell, RL; Edmond, JJ; French, JK; Aylward, PA; Simes, RJ; White, HD

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

Osoba, D. Bezjak, A. Brundage, M. Zee, B. Tu, D. Pater, J.
EUROPEAN JOURNAL OF CANCER, 2005     DOI:10.1016/j.ejca.2004.10.017

Bisphosphonates for breast cancer

Pavlakis, N Schmidt, R Stockler, M

Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain

Pollicino, CA Turner, SL Roos, DE O'Brien, PC

The effects of iodine on intelligence in children: a meta-analysis of studies conducted in China

Qian, M Wang, D Watkins, WE Gebski, V Yan, YQ Li, M Chen, ZP

Novel biostatistical retrospective audit methodology in the evaluation of adjunctive levetiracetam treatment of refractory localisation-related epilepsy

Schapel, GJ Paton, MW Roylance, RB Gebski, V

Evaluation of the quality of radiotherapy randomized trials for painful bone metastases

Shakespeare, TP Thiagarajan, A Gebski, V